ReviewBioMed research international2014
Assessment of cardiac sarcoidosis with advanced imaging modalities.
Review in BioMed research international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Cardiac Magnetic Resonance Imaging for Diagnosis of Cardiac Sarcoidosis: A Meta-Analysis.Canadian respiratory journal · 2018Pooled it
- Cardiac sarcoidosis presenting as multiple right intra-atrial masses mimicking cardiac tumor.Cardio-oncology (London, England) · 2024Article
- Current uses and understanding of PET imaging in cardiac sarcoidosis.American journal of nuclear medicine and molecular imaging · 2024Review
- Review
- Quantitative myocardial T2 mapping adds value to Japanese circulation society diagnostic criteria for active cardiac sarcoidosis.The international journal of cardiovascular imaging · 2023Article
- What Strain Analysis Adds to Diagnosis and Prognosis in Heart Failure Patients.Journal of clinical medicine · 2023Review
- Cardiac Tuberculosis onThe Indian journal of radiology & imaging · 2021Article
- Current State and Future Directions of Multimodality Imaging in Cardiac Sarcoidosis.Frontiers in cardiovascular medicine · 2021Review
- A Case of Synchronous Occurrence of Intracranial Germinoma and Systemic Sarcoidosis.NMC case report journal · 2021Article
- Multimodality Imaging to Guide Ventricular Tachycardia Ablation in Patients with Non-ischaemic Cardiomyopathy.Arrhythmia & electrophysiology review · 2020Review
- Diagnostic and predictive value of speckle tracking echocardiography in cardiac sarcoidosis.BMC cardiovascular disorders · 2020Article
- Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac Sarcoidosis.Circulation. Cardiovascular imaging · 2018Article
- Right Heart Involvement in Patients with Sarcoidosis.Echocardiography (Mount Kisco, N.Y.) · 2016Article
- Sarcoidosis of the cardio-pulmonary systems.Clinical medicine (London, England) · 2016Review
- Refractory heart failure with LBBB - Pause before CRT.Indian pacing and electrophysiology journalArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sarcoidosis is a chronic systemic disease of unknown etiology that is characterized by the presence of noncaseating epithelioid granulomas, usually in multiple organs. Several studies have shown that sarcoidosis might be the result of an exaggerated granulomatous reaction after exposure to unidentified antigens in genetically susceptible individuals. Cardiac involvement may occur and lead to an adverse outcome: the heart mechanics will be affected and that causes ventricular failure, and the cardiac electrical system will be disrupted and lead to third degree atrioventricular block, malignant ventricular tachycardia, and sudden cardiac death. Thus, early diagnosis and treatment of this potentially devastating disease is critically important. However, sensitive and accurate imaging modalities have not been established. Recent studies have demonstrated the promising potential of cardiac magnetic resonance imaging (MRI) and (18)F-fluoro-2-deoxyglucose positron emission tomography ((18)F-FDG PET) in the diagnosis and assessment of cardiac sarcoidosis (CS). In this review, we discuss the epidemiology, etiology, histological findings, and clinical features of sarcoidosis. We also introduce advanced imaging including (18)F-FDG PET and cardiac MRI as more reliable diagnostic modalities for CS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.